glp-1 antagonists Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports GLP-1 | Summary

Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis

Larry Richardson, an award-winning obesity medicine physician with over 30 years of experience, our clinic focuses on sustainable solutions that transform your health

Animal models suggest prevention of doxorubicin-induced acute hepatotoxicity occurs via suppression of intrinsic caspase-3-dependent apoptotic signaling (24)

Recalls & Warnings March 27, 2014 Three Weight Loss Supplements Containing Drugs Recalled On March 25, 2014, New Life Nutritional Center issued a voluntary recall of all lots of Super Fat Burner capsules, Maxi Gold capsules and Esmeralda softgels because they were found to contain sibutramine, phenolphthalein or a combination of both drugs

PMID 15528186